Prehospital Chest Pain Management: Disparity Based on Homeless Status
Conclusions: Significant disparities were observed between patients experiencing and not experiencing homelessness in the prehospital treatment of chest pain. Larger scale evaluations are needed to further assess potential disparities in care for people experiencing homelessness in the prehospital setting. Using prehospital clinician impression as a proxy for acuity may mask existing bias and disparity; however, 12-lead ECG acquisition, the key diagnostic tool, was appropriately performed in more than 97% of all chest pain patients.PMID:37459650 | DOI:10.1080/10903127.2023.2238309 (Source: Prehospital Emergency Care)
Source: Prehospital Emergency Care - July 17, 2023 Category: Endocrinology Authors: Travis M Curtis Omid Boozarpour Daniel E Rebagliati Christopher B Colwell Michael W Dailey Source Type: research
Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy
CONCLUSIONS: Interventions affecting the nitric oxide pathway probably do not seem to influence all-cause (fetal and neonatal) mortality in pregnant women carrying a baby with FGR, although more evidence is needed. The certainty of this evidence is moderate for sildenafil and low for tadalafil and nitroglycerin. For sildenafil a fair amount of data are available from randomised clinical trials, but with low numbers of participants. Therefore, the certainty of evidence is moderate. For the other interventions investigated in this review there are insufficient data, meaning we do not know whether these interventions improve ...
Source: Cochrane Database of Systematic Reviews - July 10, 2023 Category: General Medicine Authors: Anouk Pels Wessel Ganzevoort Louise C Kenny Philip N Baker Peter von Dadelszen Christian Gluud Chirag T Kariya Aleid G Leemhuis Katie M Groom Andrew N Sharp Laura A Magee Janus C Jakobsen Ben Willem J Mol Aris T Papageorghiou Source Type: research
Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy
CONCLUSIONS: Interventions affecting the nitric oxide pathway probably do not seem to influence all-cause (fetal and neonatal) mortality in pregnant women carrying a baby with FGR, although more evidence is needed. The certainty of this evidence is moderate for sildenafil and low for tadalafil and nitroglycerin. For sildenafil a fair amount of data are available from randomised clinical trials, but with low numbers of participants. Therefore, the certainty of evidence is moderate. For the other interventions investigated in this review there are insufficient data, meaning we do not know whether these interventions improve ...
Source: Cochrane Database of Systematic Reviews - July 10, 2023 Category: General Medicine Authors: Anouk Pels Wessel Ganzevoort Louise C Kenny Philip N Baker Peter von Dadelszen Christian Gluud Chirag T Kariya Aleid G Leemhuis Katie M Groom Andrew N Sharp Laura A Magee Janus C Jakobsen Ben Willem J Mol Aris T Papageorghiou Source Type: research
